4.5 Review

The reverse operation of Na+/Cl--coupled neurotransmitter transporters - why amphetamines take two to tango

Journal

JOURNAL OF NEUROCHEMISTRY
Volume 112, Issue 2, Pages 340-355

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1471-4159.2009.06474.x

Keywords

carrier-mediated release; clinical therapeutics; drug targets; neurotransmitter transporters; reverse operation; transporter-mediated release

Funding

  1. Austrian Science fund/FWF [P18706, SFB35]
  2. NIH [P41 RR-01081]
  3. NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Sodium-chloride coupled neurotransmitter transporters achieve reuptake of their physiological substrate by exploiting the pre-existing sodium-gradient across the cellular membrane. This terminates the action of previously released substrate in the synaptic cleft. However, a change of the transmembrane ionic gradients or specific binding of some psychostimulant drugs to these proteins, like amphetamine and its derivatives, induce reverse operation of neurotransmitter:sodium symporters. This effect eventually leads to an increase in the synaptic concentration of non-exocytotically released neurotransmitters [and - in the case of the norepinephrine transporters, underlies the well-known indirect sympathomimetic activity]. While this action has long been appreciated, the underlying mechanistic details have been surprisingly difficult to understand. Some aspects can be resolved by incorporating insights into the oligomeric nature of transporters, into the nature of the accompanying ion fluxes, and changes in protein kinase activities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available